Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Intercept stock triples on liver disease study
Intercept stock triples on liver disease study
Intercept stock triples on liver disease study
Submitted by
admin
on January 10, 2014 - 8:20am
Source:
Yahoo/AP
News Tags:
Intercept Pharma
liver disease
obeticholic acid
Headline:
Intercept stock triples on liver disease study
Do Not Allow Advertisers to Use My Personal information
